We are live on ! Find out more
SC

Scholtz & Company Portfolio holdings

AUM $195M
1-Year Est. Return 12.04%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+12.04%
3 Year Est. Return
+82.55%
5 Year Est. Return
+94.25%
10 Year Est. Return
+790.35%
AUM
$101M
AUM Growth
-$4.31M
Cap. Flow
-$2.6M
Cap. Flow %
-2.57%
Top 10 Hldgs %
39.07%
Holding
82
New
4
Increased
21
Reduced
40
Closed
15

Sector Composition

Rank Sector Weight
1 Financials 20.92%
2 Energy 15.4%
3 Technology 10.6%
4 Real Estate 9.25%
5 Communication Services 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XYL icon
76
Xylem
XYL
$28.5B
-5,450
Closed -$213K
DBD
77
DELISTED
Diebold Nixdorf Incorporated
DBD
-6,000
Closed -$241K
CHSP
78
DELISTED
Chesapeake Lodging Trust
CHSP
-74,825
Closed -$2.26M
UN
79
DELISTED
Unilever NV New York Registry Shares
UN
-6,900
Closed -$302K

Similar funds

Scholtz & Company's Q3 2014 Portfolio in Review

As of Q3 2014, Scholtz & Company held 82 positions worth $101M, down 4.1% from $106M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Scholtz & Company's Q3 2014 filing shows 4 new, 21 increased, 40 reduced and 15 closed positions. Its largest new stake was Medtronic: 59,760 shares worth $3.7M. The largest sale was Chesapeake Lodging Trust, an estimated $2.26M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 18% a quarter earlier, followed by Energy and Technology.

  • Scholtz & Company's largest Q3 2014 buy was Medtronic: 59,760 shares worth $3.7M.
  • Scholtz & Company added most to Chatham Lodging in Q3 2014, an estimated $3.29M increase.
  • Scholtz & Company's biggest Q3 2014 reduction was Gilead Sciences, cutting an estimated $2.13M.
  • Scholtz & Company fully exited Chesapeake Lodging Trust in Q3 2014, selling an estimated $2.26M.
  • Scholtz & Company's ten largest holdings make up 39% of its $101M portfolio in Q3 2014.
  • Scholtz & Company opened 4 new positions and closed 15 in Q3 2014.
  • Scholtz & Company's portfolio value fell 4.1% quarter-over-quarter to $101M.

Based on Scholtz & Company's 13F filing for Q3 2014, filed 13 Nov 2014.